Cytokeratin 8/18 抗体
(18 references)-
- 抗原 See all Cytokeratin 8/18 products
- Cytokeratin 8/18
-
适用
- Cow
-
宿主
-
豚鼠
-
克隆类型
- 多克隆
-
标记
- This Cytokeratin 8/18 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), ELISA
- 纯度
- Stabilized antiserum
- 免疫原
- Cytokeratin 8/8 antibody was raised in guinea pig using cytokeratin 8/18 filaments, reconstituted from purified bovine cytokeratins 8 and 18 as the immunogen.
- 亚型
- IgG
-
anti-Cytokeratin 8/18 antibody (FITC)
适用: 人 FACS, IHC (p), IHC, ICC 宿主: 小鼠 Monoclonal CK 209 FITC
anti-Cytokeratin 8/18 antibody适用: 人 FACS, WB, IF, IHC, StM 宿主: 小鼠 Monoclonal B22-1-B23-1 unconjugated
anti-Cytokeratin 8/18 antibody适用: 人 FACS, WB, IF, IHC (p) 宿主: 小鼠 Monoclonal KRT8-803-KRT18-835 unconjugated
anti-Cytokeratin 8/18 antibody适用: 人 FACS, WB, IF, IHC (p) 宿主: 小鼠 Monoclonal KRT8-803-KRT18-835 unconjugated
anti-Cytokeratin 8/18 antibody适用: 人, Cow, 猴, Pig, 绵羊 FACS, WB, IF, IHC (p) 宿主: 小鼠 Monoclonal C-51 unconjugated
anti-Cytokeratin 8/18 antibody适用: 人, Cow, 猴, Pig, 绵羊 FACS, WB, IF, IHC (p) 宿主: 小鼠 Monoclonal C-51 unconjugated
-
- 应用备注
- IHC-F: 1:100, IHC-P: 1:50, WB: 1:2,000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- Supplied as whole antiserum with 0.09 % NaN3.
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
- 储存条件
- 4 °C
- 储存方法
- Store at 4 °C
-
-
: "An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction." in: PLoS ONE, Vol. 15, Issue 7, pp. e0232564, (2020) (PubMed).
: "Rheb1-Independent Activation of mTORC1 in Mammary Tumors Occurs through Activating Mutations in mTOR." in: Cell reports, Vol. 31, Issue 4, pp. 107571, (2020) (PubMed).
: "The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor." in: Disease models & mechanisms, Vol. 12, Issue 7, (2020) (PubMed).
: "A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials." in: Journal of mammary gland biology and neoplasia, Vol. 24, Issue 2, pp. 149-162, (2020) (PubMed).
: "Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program." in: Nature communications, Vol. 9, Issue 1, pp. 2547, (2018) (PubMed).
: "MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. ..." in: Nature communications, Vol. 8, Issue 1, pp. 1728, (2018) (PubMed).
: "Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix." in: Molecular biology of the cell, Vol. 28, Issue 11, pp. 1467-1488, (2017) (PubMed).
: "Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling." in: Oncogene, Vol. 35, Issue 35, pp. 4641-52, (2017) (PubMed).
: "The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα." in: Nature, Vol. 541, Issue 7638, pp. 541-545, (2017) (PubMed).
: "Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis." in: Oncotarget, Vol. 6, Issue 26, pp. 22890-904, (2016) (PubMed).
: "Inhibition of BMP signaling suppresses metastasis in mammary cancer." in: Oncogene, Vol. 34, Issue 19, pp. 2437-49, (2015) (PubMed).
: "Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk." in: Breast cancer research : BCR, Vol. 14, Issue 4, pp. R98, (2015) (PubMed).
: "Endothelial Expression of Scavenger Receptor Class B, Type I Protects against Development of Atherosclerosis in Mice." in: BioMed research international, Vol. 2015, pp. 607120, (2015) (PubMed).
: "Runx2 contributes to the regenerative potential of the mammary epithelium." in: Scientific reports, Vol. 5, pp. 15658, (2015) (PubMed).
: "Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. ..." in: Cancer discovery, Vol. 4, Issue 2, pp. 232-45, (2014) (PubMed).
: "RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland." in: Disease models & mechanisms, Vol. 7, Issue 5, pp. 525-34, (2014) (PubMed).
: "Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo." in: PLoS ONE, Vol. 7, Issue 11, pp. e48651, (2013) (PubMed).
: "Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors." in: Cancer research, Vol. 72, Issue 6, pp. 1485-93, (2012) (PubMed).
-
: "An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction." in: PLoS ONE, Vol. 15, Issue 7, pp. e0232564, (2020) (PubMed).
-
- 抗原
- Cytokeratin 8/18
- 别名
- Cytokeratin 8 +18 (Cytokeratin 8/18 产品)
-
